DexCom, Inc.
DXCM
$66.33
$0.711.08%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.64% | 15.21% | 12.49% | 7.64% | 1.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.64% | 15.21% | 12.49% | 7.64% | 1.97% |
| Cost of Revenue | 19.36% | 24.02% | 24.48% | 21.12% | 13.85% |
| Gross Profit | 23.17% | 9.91% | 4.82% | -0.12% | -4.73% |
| SG&A Expenses | 8.16% | -1.41% | -2.88% | 7.84% | 6.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.79% | 11.60% | 10.05% | 13.09% | 9.45% |
| Operating Income | 59.54% | 34.56% | 32.25% | -12.91% | -26.03% |
| Income Before Tax | 98.59% | 28.38% | 16.45% | -14.18% | -26.21% |
| Income Tax Expenses | 60.05% | 38.37% | 451.80% | 690.10% | -64.24% |
| Earnings from Continuing Operations | 110.85% | 25.30% | -28.01% | -40.81% | 11.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 110.85% | 25.30% | -28.01% | -40.81% | 11.52% |
| EBIT | 59.54% | 34.56% | 32.25% | -12.91% | -26.03% |
| EBITDA | 47.66% | 31.18% | 26.11% | -8.43% | -18.29% |
| EPS Basic | 112.47% | 27.57% | -28.17% | -41.80% | 9.39% |
| Normalized Basic EPS | 100.14% | 30.71% | 16.21% | -15.60% | -27.61% |
| EPS Diluted | 109.87% | 27.45% | -25.82% | -39.07% | 15.67% |
| Normalized Diluted EPS | 99.96% | 31.11% | 19.12% | -12.24% | -23.21% |
| Average Basic Shares Outstanding | -0.79% | -1.78% | 0.23% | 1.69% | 1.97% |
| Average Diluted Shares Outstanding | -0.68% | -2.06% | -2.21% | -2.21% | -3.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |